Theratechnologies EV/EBIT
Cos'è EV/EBIT di Theratechnologies?
EV/EBIT di Theratechnologies Inc. è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Theratechnologies
Cosa fa Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Aziende con ev/ebit simili a Theratechnologies
- DATATRAK International ha EV/EBIT di N/A
- New York Mortgage Trust Inc ha EV/EBIT di N/A
- Surface Oncology Inc ha EV/EBIT di N/A
- Deciphera Pharmaceuticals Inc ha EV/EBIT di N/A
- Nymox Pharmaceutical Corp ha EV/EBIT di N/A
- Walker River Resources ha EV/EBIT di N/A
- Theratechnologies ha EV/EBIT di N/A
- Palred Technologies ha EV/EBIT di N/A
- Eton Pharmaceuticals ha EV/EBIT di N/A
- The Very Good Food ha EV/EBIT di N/A
- Jangada Mines Plc ha EV/EBIT di N/A
- Northern Lion Gold ha EV/EBIT di N/A
- Just Plc ha EV/EBIT di N/A